Opendata, web and dolomites

LOUISA-3D

Clinical validation of Laser Optoacoustic Ultrasonic 3D Imaging System Assembly for breast cancer detection and characterization through endogenous biomarkers.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LOUISA-3D project word cloud

Explore the words cloud of the LOUISA-3D project. It provides you a very rough idea of what is the project "LOUISA-3D" about.

louisa    affordable    committee    ce    ultrasonic    commercializes    screening    standard    opportunity    functional    nat    content    cancer    blood    view    mammography    effect    medical    market    coregistered    sensitivity    media    trials    trial    introducing    resolution    clinical    modality    representing    risk    predictive    exogenous    3d    bc    validated    female    validating    oxygen    digital    feasibility    ultrasound    images    once    validate    recall    enter    company    device    anatomical    radiation    treatment    plan    enhanced    scientific    protocols    positive    contrast    endogenous    imaging    women    tomography    first    board    overcome    capability    therapy    combines    diagnostic    full    financial    laser    optoacoustic    ionizing    resonance    release    commercialized    deaths    population    neoadjuvant    bios    saturation    biomarkers    marked    hemoglobin    characterization    assembly    limitations    business    worldwide    manufactured    complete    rate    bcs    locally    measuring    magnetic    detection    safe    breast    commercialization    international    evaluation   

Project "LOUISA-3D" data sheet

The following table provides information about the project.

Coordinator
BIOS S.R.L. 

Organization address
address: VIA GUIDO ROSSA, 10/12
city: VIMODROME
postcode: 20090
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website https://ec.europa.eu/easme/en/sme/5478/clinical-validation-laser-optoacoustic-ultrasonic-3d-imaging-system-assembly-breast-cancer
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOS S.R.L. IT (VIMODROME) coordinator 50˙000.00

Map

 Project objective

Breast cancer (BC) is the most common cancer and the first cause of cancer-related deaths in European women. Laser Optoacoustic Ultrasonic 3D Imaging System Assembly (LOUISA-3D) combines optoacoustic functional information from endogenous biomarkers (hemoglobin content and blood oxygen saturation) with high-resolution anatomical images of ultrasound tomography, without the need for ionizing radiation or exogenous contrast media. The objective of LOUISA-3D is to overcome the main limitations of current imaging methods, by validating and introducing to the EU market a novel multi-modality diagnostic device for BC, based on coregistered full view 3D optoacoustic and ultrasonic technology. LOUISA-3D will be a highly effective, safe and affordable imaging method for BC detection, characterization, and evaluation of the effect of neoadjuvant therapy (NAT). Two clinical trials will validate LOUISA-3D. Trial 1 will measure detection rate, recall rate, sensitivity, and positive predictive value of LOUISA-3D as a screening test in a selected female population at increased risk for BC, as compared to standard digital mammography. Trial 2 will assess the LOUISA-3D endogenous biomarkers capability of measuring the NAT effect in the treatment of locally advanced BCs, as compared to contrast-enhanced magnetic resonance imaging. During this feasibility study, an international scientific committee will deliver both trial protocols, and a management board will release a work and financial plan for the trials and a business plan for the production and commercialization of LOUISA-3D, complete market analysis, cost analysis and financial plan. The applying company, Bios, commercializes medical laser systems worldwide. Once validated and CE medical marked, LOUISA-3D will be manufactured and commercialized in EU, representing an important opportunity for Bios to enter the medical imaging market and enable its significant growth.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LOUISA-3D" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LOUISA-3D" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More